Table 1: Studies on JCV and kidney transplantation.

Subjects (n)SampleJCV (+)/subjects (%)Pathological correlationReference

KTx: 103Urine
Blood
23/103 (22.3%)
0/103 (0%)
None [21]
Controls: 23Urine
Blood
8/23 (34.7%)
0/23 (0%)

KTx: 103Urine
Blood
28/103 (27.2%)
15/103 (14.2%)
None [22]
Controls: 0//

KTx: 76Urine
Blood
12/76 (15.8%)
0/76 (0%)
None [23]
Controls: 0//

KTx: 68Urine14/68 (21%)None [24]
Controls: 0//

KTx: 60Urine24/60 (40%)None [25]
Controls: 60Urine11/60 (18.3%)

KTx: 186Urine33/186 (17.8%)None [26]
Controls: 0//

KTx: 25Urine
Serum
6/25 (24%)
6/25 (24%)
None [21]
Controls: 20Urine3/20 (15%)

KTx: 52Urine8/52 (15.4%)None [27]
Controls: 30Urine0/30 (0%)

KTx: 59Urine2/59 (3.4%)
CRD: 102Urine4/102 (3.9%)None[28]
Controls: 134Urine27/134 (20.1%)

KTx: 103Blood7/103 (6.8%) None [29]
Controls: 0//

KTx: 30Urine7/30 (23.3%)None [30]
Controls: 30Urine7/30 (23.3%)

KTx: 30Urine5/30 (16.7%)None [31]
Controls: 0//

KTx: kidney transplant recipients; CRD: chronic renal diseases.